Overview
The MicroEye® is inserted through a conventional 18G venous access device, its tip within the circulating blood of the patient.
- Enables continuous, online and automated monitoring of substances in circulating blood without withdrawing blood from the patient
- Can provide virtually real-time information
- Inserted using all common peripheral venous catheters
- Easy to use and reduces risks of contact with blood borne pathogens
- Produces a 'plasma-like' sample without the need for blood centrifugation
- Samples can be collected for off-line analysis if required
Having successfully completed the relevant legal processes for approval and CE marking, the MicroEye® is now available for use in Europe.
The MicroEye® is intended for intravenous use for periods of up to 48 hours and is inserted via an 18G blood catheter. It mimics the normal physiological process of chemical transport taking place between
The range of substances that can be monitored using the MicroEye® is vast including:
- Electrolytes (such as potassium, magnesium etc.)
tissues and fluids.
- Energy metabolites (e.g. glucose, lactate, pyruvate, etc.)
- Amino acids (glutamate, GABA, etc.)
- Hormones and neurotransmitters (such as dopamine, serotonin (5-HT) etc.)
- Inflammatory mediators and growth factors (e.g. cytokines, etc.)
- Drugs and their metabolites (unbound ‘free’ fraction and / or total)
Need more information or advice?
For further technical information or advice on using the MicroEye® please complete our contact form.